BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8501488)

  • 1. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.
    Anderson JR; Jenkin RD; Wilson JF; Kjeldsberg CR; Sposto R; Chilcote RR; Coccia PF; Exelby PR; Siegel S; Meadows AT
    J Clin Oncol; 1993 Jun; 11(6):1024-32. PubMed ID: 8501488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Tubergen DG; Krailo MD; Meadows AT; Rosenstock J; Kadin M; Morse M; King D; Steinherz PG; Kersey JH
    J Clin Oncol; 1995 Jun; 13(6):1368-76. PubMed ID: 7751881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
    Sposto R; Meadows AT; Chilcote RR; Steinherz PG; Kjeldsberg C; Kadin ME; Krailo MD; Termuhlen AM; Morse M; Siegel SE
    Med Pediatr Oncol; 2001 Nov; 37(5):432-41. PubMed ID: 11745871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group.
    Jenkin RD; Anderson JR; Chilcote RR; Coccia PF; Exelby PR; Kersey JH; Kushner JH; Meadows AT; Siegel SE; Sposto R
    J Clin Oncol; 1984 Feb; 2(2):88-97. PubMed ID: 6366148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.
    Meadows AT; Sposto R; Jenkin RD; Kersey JH; Chilcote RR; Siegel SE; Coccia PF; Rosenstock J; Pringle KC; Stolar CJ
    J Clin Oncol; 1989 Jan; 7(1):92-9. PubMed ID: 2642543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
    Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
    An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of various therapeutic protocols on growth and final height of children with acute lymphoblastic leukemia or non-Hodgkin's lymphoma].
    Timme J; Mittler U; Mohnike K; Dörffel W
    Klin Padiatr; 1995; 207(5):267-70. PubMed ID: 7500601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
    Prats Viñas J; Gallego Melcón S; Pérez Payarols J; Macía Martí J; Sánchez de Toledo J
    An Esp Pediatr; 1987 Jan; 26(1):15-21. PubMed ID: 3826937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
    Nachman J
    Am J Pediatr Hematol Oncol; 1990; 12(3):359-66. PubMed ID: 2240485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-Hodgkin's lymphoma in children. Study of 30 patients at the Caracas University Hospital].
    Acquatella G; Urdaneta N; Rosas Uribe A; García Guevara R
    Sangre (Barc); 1985; 30(3):253-83. PubMed ID: 3839940
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of modified LSA2L2 therapy in children with non-Hodgkin's lymphoma].
    Shitara T; Kuribayashi T; Oshima Y; Suetake N; Hiraishi Y
    Rinsho Ketsueki; 1984 Oct; 25(10):1594-9. PubMed ID: 6549186
    [No Abstract]   [Full Text] [Related]  

  • 16. Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
    Finlay JL; Anderson JR; Cecalupo AJ; Hutchinson RJ; Kadin ME; Kjeldsberg CR; Provisor AJ; Woods WG; Meadows AT
    Med Pediatr Oncol; 1994; 23(6):453-63. PubMed ID: 7935170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.
    Lones MA; Perkins SL; Sposto R; Tedeschi N; Kadin ME; Kjeldsberg CR; Wilson JF; Zwick DL; Cairo MS
    J Clin Oncol; 2002 May; 20(9):2293-301. PubMed ID: 11981000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
    Wróbel G; Bogusławska-Jaworska J; Kazanowska B; Armata J; Bubała H; Dłuzniewska A; Kołecki P; Kowalczyk J; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stefańska K; Matysiak M; Stańczak E
    Wiad Lek; 1998; 51 Suppl 4():18-24. PubMed ID: 10731939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
    Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
    Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
    Teodorovic I; Pittaluga S; Kluin-Nelemans JC; Meerwaldt JH; Hagenbeek A; van Glabbeke M; Somers R; Bijnens L; Noordijk EM; Peeters CD
    J Clin Oncol; 1995 Nov; 13(11):2819-26. PubMed ID: 7595744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.